PSivida (PSDV, $2.55, $0.51, 25.00%) shares jumped after the...

PSivida (PSDV, $2.55, $0.51, 25.00%) shares jumped after the company signed an
exclusive worldwide collaborative research agreement with Pfizer Inc. (PFE, $25.79,
$0.12, 0.47%) for work on PSivida's controlled drug deliver technologies. The deal
calls for the Perth, Australia, nanotechnology company said it will receive up to $155
million and in development and sales milestones. Pfizer also agreed to fund the joint
research program and to buy $5 million worth of pSivida shares upon entering the license
agreement and another $5 million in the future.